protection < protective < protects

Facettes : Author.f AffPays.f AffOrg.f AffRegion.f AffVille.f

List of bibliographic references

Number of relevant bibliographic references: 52.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000003 (2016)	Naomi Komadina [Australie] ; Sergio M. Qui Ones-Parra [Australie] ; Katherine Kedzierska [Australie] ; James M. Mccaw [Australie] ; Anne Kelso [Australie] ; Karin Leder [Australie] ; Jodie Mcvernon [Australie]	High conservation level of CD8+ T cell immunogenic regions within an unusual H1N2 human influenza variant
000014 (1998)	A. Natali [Italie] ; E. Pilotti [Italie] ; P. O. Valcavi [Italie] ; C. Chezzi [Italie] ; J. S. Oxford [Royaume-Uni]	Natural and ‘ In vitro ’ selected antigenic variants of influenza A virus (H2N2)
000036 (2002)	N. Hehme [Allemagne] ; H. Engelmann [Allemagne] ; W. Künzel [Allemagne] ; E. Neumeier [Allemagne] ; R. S Nger [Allemagne]	Pandemic preparedness: lessons learnt from H2N2 and H9N2 candidate vaccines
000090 (1986)	G. I. Alexandrova [Russie] ; G. N. Budilovsky [Russie] ; T. A. Koval [Russie] ; F. I. Polezhaev [Russie] ; L. M. Garmashova [Russie] ; Yu. Z. Ghendon [Russie] ; Y. R. Romanova [Russie] ; A. A. Smorodintsev [Russie]	Study of live recombinant cold-adapted influenza bivalent vaccine of type A for use in children: an epidemiological control trial
000104 (1988)	Robert F. Betts [États-Unis] ; R. Gordon Douglas ; Hunien F. Maassab Jr. ; Dan C. Deborde ; Mary Lou Clements [États-Unis] ; Brian R. Murphy	Analysis of virus and host factors in a study of A/Peking/2/79 (H3N2) cold‐adapted vaccine recombinant in which vaccine‐associated illness occurred in normal volunteers
000134 (2001)	M. D. Wareing [Australie] ; J. M. Watson [Australie] ; M. J. Brooks [Australie] ; G. A. Tannock [Australie]	Immunogenic and isotype‐specific responses to russian and US cold‐adapted influenza a vaccine donor strains A/Leningrad/134/17/57, A/Leningrad/134/47/57, and A/Ann Arbor/6/60 (H2N2) in mice
000180 (1986)	M. E. Andrew [Australie] ; B. E. H. Coupar [Australie] ; G. L. Ada [Australie] ; D. B. Boyle [Australie]	Cell-mediated immune responses to influenza virus antigens expressed by vaccinia virus recombinants
000182 (2001)	D. L Major [Royaume-Uni] ; R. W Newman [Royaume-Uni] ; U. Dunleavy [Royaume-Uni] ; A. B Heath [Royaume-Uni] ; K. Ploss [Royaume-Uni] ; J. M Wood [Royaume-Uni]	Evaluation of H9N2 influenza vaccines in Balb/c mice
000188 (1992)	Susan B. Dillon [États-Unis] ; Sandra G. Demuth [États-Unis] ; Mark A. Schneider [États-Unis] ; Cynthia B. Weston [États-Unis] ; Christopher S. Jones [États-Unis] ; James F. Young [États-Unis] ; Miller Scott [États-Unis] ; Pradip K. Bhatnaghar [États-Unis] ; Stephen Locastro [États-Unis] ; Nabil Hanna [États-Unis]	Induction of protective class I MHC-restricted CTL in mice by a recombinant influenza vaccine in aluminium hydroxide adjuvant
000251 (2007)	Jindrich Cinatl Jr [Allemagne] ; Martin Michaelis [Allemagne] ; Hans W. Doerr [Allemagne]	The threat of avian influenza A (H5N1). Part IV: development of vaccines
000397 (1981)	John M. Quarles [États-Unis] ; Robert B. Couch [États-Unis] ; Thomas R. Cate [États-Unis] ; Claude B. Goswick [États-Unis]	Comparison of amantadine and rimantadine for prevention of type A (Russian) influenza
000448 (1978)		Influenza vaccination this year
000466 (2012)	R. Allwinn [Allemagne] ; M. Bickel [Allemagne] ; C. Lassmann [Allemagne] ; S. Wicker [Allemagne] ; I. Friedrichs [Allemagne]	“Trivalent influenza vaccination of healthy adults 3 years after the onset of swine-origin H1N1 pandemic: restricted immunogenicity of the new A/H1N1v constituent?”
000505 (1996)	Claire E. Parker [Royaume-Uni] ; Keith G. Gould [Royaume-Uni]	Influenza A virus—a model for viral antigen presentation to cytotoxic T lymphocytes
000515 (1995)	Vladimir A. Slepushkin [États-Unis] ; Jacqueline M. Katz [États-Unis] ; Renee A. Black [États-Unis] ; William C. Gamble [États-Unis] ; Paul A. Rota [États-Unis, Russie] ; Nancy J. Cox [États-Unis]	Protection of mice against influenza A virus challenge by vaccination with baculovirus-expressed M2 protein
000520 (1978)	Ch. Kunz [Autriche] ; H. Hofmann [Autriche] ; A. Moritz [Autriche] ; H. Bachmayer [Autriche] ; E. Liehl [Autriche]	Eine neue Influenza Subunit Vakzine: Hämagglutinations-hemmende Antikörper ein Jahr nach der Impfung
000525 (1997)	Julia R. Romanova [Russie] ; Gregory A. Tannock [Australie] ; Galina I. Alexandrova [Russie]	Protective responses in mice to vaccination with multiply administered cold-adapted influenza vaccine reassortants and wild-type viruses
000531 (1990)	Paul A. Rota [États-Unis] ; Barun K. De [États-Unis] ; Michael W. Shaw [États-Unis] ; Renee A. Black [États-Unis] ; William C. Gamble [États-Unis] ; Alan P. Kendal [États-Unis]	Comparison of inactivated, live and recombinant DNA vaccines against influenza virus in a mouse model
000551 (1994)	K. Scheepers [Allemagne] ; H. Becht [Allemagne]	Protection of mice against an influenza virus infection by oral vaccination with viral nucleoprotein incorporated into immunostimulating complexes
000584 (2000)	K. Subbarao [États-Unis] ; J. Katz [États-Unis]	Avian influenza viruses infecting humans
000589 (1996)	Gordon Ada	Do cytotoxic T lymphocytes clear some HIV/SIV infections?

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/Istex/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i -k "protective" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i  \
                -Sk "protective" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    H2N2V1
   |flux=    Istex
   |étape=   Curation
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    protective
}}

---

This area was generated with Dilib version V0.6.33. Data generation: Tue Apr 14 19:59:40 2020. Site generation: Thu Mar 25 15:38:26 2021